Congenital anomaly rate in offspring of mothers with diabetes treated with insulin lispro during pregnancy
- 21 May 2005
- journal article
- research article
- Published by Wiley in Diabetic Medicine
- Vol. 22 (6), 803-807
- https://doi.org/10.1111/j.1464-5491.2004.01498.x
Abstract
Aim To determine the rate of major congenital anomalies in offspring of a large group of women with diabetes mellitus treated with insulin lispro (Humalog®). Methods This multinational, multicentre, retrospective study included mothers with diabetes mellitus (diagnosed prior to conception) who were treated with insulin lispro for at least 1 month before conception and during at least the first trimester of pregnancy. Anomalies were assessed by two independent dysmorphologists not affiliated with the sponsor. Results The charts of 496 women were reviewed for 533 pregnancies resulting in 542 offspring (500 live births, 31 spontaneous and seven elective abortions, and four stillbirths). Mothers’ characteristics: mean (± sd) age was 29.9 (± 5.2) years, 85.6% were Caucasian and 97.2% had Type 1 diabetes mellitus. Insulin lispro continued to be the main mealtime insulin for more than 96% of the women during the second and third trimester. The dysmorphologists determined that 27 (5.4%) offspring had major congenital anomalies and 2 (0.4%) offspring had minor congenital anomalies. Conclusions The rate of major congenital anomalies was 5.4%[95% CI (3.45%, 7.44%)] for offspring of mothers with diabetes mellitus treated with insulin lispro before and during pregnancy. The current published rates of major anomalies in infants born to mothers with diabetes treated with insulin are between 2.1 and 10.9%. This suggests that the anomaly rate with insulin lispro treatment does not differ from the published major congenital anomaly rates for other insulin treatments.Keywords
This publication has 27 references indexed in Scilit:
- Management of Dyslipidemia in Children and Adolescents With DiabetesDiabetes Care, 2003
- Preconception Care of Women With DiabetesDiabetes Care, 2003
- Are recurrent pregnancies a risk in Type 1 diabetes?Acta Obstetricia et Gynecologica Scandinavica, 2002
- Maternal diabetes mellitus and infant malformationsObstetrics & Gynecology, 2002
- Insulin Lispro in pregnancy - retrospective analysis of 33 cases and matched controlsExperimental and Clinical Endocrinology & Diabetes, 2002
- Preliminary experience with the use of insulin lispro in pregnant diabetic womenJournal of Obstetrics and Gynaecology, 2001
- Epidemiological analysis of outcomes of pregnancy in diabetic mothers: Identification of the most characteristic and most frequent congenital anomaliesAmerican Journal of Medical Genetics, 1994
- Preconception care of diabetes. Glycemic control prevents congenital anomaliesPublished by American Medical Association (AMA) ,1991
- First‐trimester hemoglobin A1 and risk for major malformation and spontaneous abortion in diabetic pregnancyTeratology, 1989
- Errors of morphogenesis: Concepts and termsThe Journal of Pediatrics, 1982